SIGA

SIGA Technologies, Inc. [SIGA] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

SIGA Stock Summary

In the News

SIGA Financial details

Company Rating
-
Market Cap
626.32M
Income
68.07M
Revenue
139.92M
Book val./share
-
Cash/share
-
Dividend
0.45
Dividend %
8.46%
Employees
45
Optionable
No
Shortable
Yes
Earnings
01 Mar 2024
P/E
-75.66
Forward P/E
-
PEG
-6.94
P/S
10.87
P/B
3.05
P/C
-
P/FCF
49.37
Quick Ratio
2.57
Current Ratio
4.75
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.96
EPS next Y
-
EPS next Q
-
EPS this Y
106.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
39.23%
Revenue Q/Q
1161.27%
EPS Q/Q
-18645.45%
-
-
-
-
SMA20
-
SMA50
16.67%
SMA100
-22.22%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-3%
ROC
-0.08%
Gross Margin
31%
Oper. Margin
-28%
Profit Margin
-14%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.22-10.0
52W High
-32.35%
52W Low
+69.13%
RSI
53
Rel Volume
0.24
Avg Volume
753.93K
Volume
180.36K
Perf Week
-0.37%
Perf Month
2.66%
Perf Quarter
-21.43%
Perf Half Y
-22.24%
-
-
-
-
Beta
0.969
-
-
Volatility
0.04%, 0.1%
Prev Close
0.82%
Price
6.765
Change
-0.95%

SIGA Financial Performance

SIGA Dividend History

SIGA Frequently Asked Questions

What is SIGA Technologies, Inc. stock symbol ?

SIGA Technologies, Inc. is a US stock , located in New york of Ny and trading under the symbol SIGA

What is SIGA Technologies, Inc. stock quote today ?

SIGA Technologies, Inc. stock price is $6.765 today.

Is SIGA Technologies, Inc. stock public?

Yes, SIGA Technologies, Inc. is a publicly traded company.

Something similar

Top by Market Cap
BRK-A
ABEA.DE
1YD.DE
FXAIX
TL0.DE
Same Sector
ZOM
DCAL.NS
PRLX
STX.L
INNV
Same Price Range
NYXH
DGR.DE
600210.SS
TOPS
MID-UN.TO
Similar Market Cap
DLX
YINN
CVG.TO
ETDD.DE
CCRN

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 753.93K
  • Market Capitalization 626.32M
  • Employee 45
  • CEO Dr. Diem Nguyen M.B.A., Ph.D.
  • Headquarters New York,NY,US
  • IPO Date 1997-09-10
  • Website https://www.siga.com

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.